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Abstract
Background: Awareness about paradoxical reactions in tuberculous meningitis is crucial as a paradoxical reaction
may lead to certain wrong conclusions (for example, an erroneous diagnosis, and a possibility of treatment failure,
mycobacterial drug-resistance, drug toxicity, or presence of a malignancy). The present study was planned to
evaluate the incidence and predictive factors of paradoxical reactions in light of clinical, cerebrospinal fluid, and
neuroimaging characteristics.
Methods: In this prospective cohort study, consecutive patients fulfilling the International Consensus criteria of
tuberculous meningitis were included. Patients were subjected to clinical evaluation, cerebrospinal fluid evaluation,
and neuroimaging. Patients were treated with anti-tuberculosis drugs along with corticosteroids. Patients were
regularly followed up at 3 monthly intervals. At each follow up patients were evaluated clinically and repeat
cerebrospinal fluid analysis was performed along with repeat neuroimaging. Disability assessment was done
using Barthel index.
Results: We enrolled 141 patients of tuberculous meningitis. Approximately one-third of patients (44/141; 31.2 %)
developed a paradoxical reaction. Twenty-seven patients developed hydrocephalus, 26 developed tuberculomas, 12
developed optochiasmatic arachnoiditis and 4 patients had spinal arachnoiditis. In 41 patients (out of 44) cerebrospinal
fluid paradoxically worsened (increase in cells and/or protein); 2 demonstrated a decrease in cells with polymorph
predominance while in one it was normal. In 3 patients, paradoxical cerebrospinal fluid changes were not associated with
neuroimaging changes. On multivariate analysis, predictors of paradoxical reaction were female gender (p = 0.013), HIV
positivity (p= 0.01) and a shorter duration of illness (p = 0.049). Development of paradoxical reactions did not predict the
disability status of the patients.
Conclusions: Paradoxical reaction occurs in approximately one-third of patients with tuberculous meningitis. Female
gender, concomitant HIV infection, and a shorter duration of illness were significant predictors. Paradoxical reactions did
not adversely affect the outcome.
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Background
Paradoxical reaction, in patients with tuberculous men-
ingitis, is characterized by either worsening of pre-
existing tuberculous lesions or the appearance of new
tuberculous lesions in patients who show initial im-
provement following anti-tuberculosis treatment. The
clinical or radiological deterioration associated with such
a reaction may fallaciously suggest either a drug resistant
state or treatment failure, and might even prompt to
look for an alternative diagnosis [1–3]. The manifesta-
tions of paradoxical reaction, that have been described,
are mostly derived from case reports and small case
series. These include a variety of clinical manifestations
and neuroimaging abnormalities, along with an altered
cerebrospinal fluid picture. Cerebrospinal fluid changes
may include lymphocytic pleocytosis, a change in cellu-
lar components in the direction of polymorphonuclear
predominance, or an increase in protein levels. Paradox-
ical reaction does not necessarily represent treatment
failure and corticosteroids have been shown to have a
beneficial effect [4–6].
In human immunodeficiency virus (HIV)-infected pa-
tients, paradoxical reactions are termed as the immune
reconstitution inflammatory syndrome (IRIS), which is a
condition characterized with worsening of pre-existing
infective processes, following treatment with antiretro-
viral therapy. Tuberculosis-associated immune reconsti-
tution inflammatory syndrome is characterized by
worsening of clinical symptoms, signs, and imaging
characteristics of tuberculosis subsequent to initiation of
antiretroviral therapy after initial improvement with
anti-tuberculosis treatment [7, 8].
Most of the current information about paradoxical reac-
tion in tuberculous meningitis is in the form of isolated
case reports, small case series, and articles with small num-
ber of patients. The exact frequency and spectrum of para-
doxical reaction is not precisely known. Its impact on
prognosis is also not clear. This prospective follow up study
has been planned to answer all these questions.
Methods
This prospective study was conducted in Department of
Neurology, King George Medical University Uttar Pradesh,
Lucknow. Our institute is a tertiary care hospital serving a
population of approximately 100 million. It is situated in an
area which is highly endemic for tuberculosis. Formal eth-
ical approval was taken from the Institutional Ethics
Committee, King George’s Medical University, U.P., India.
Written informed consent was obtained from all patients
and/or their legal guardians.
Inclusion criteria
All consecutive newly-diagnosed patients of tuberculous
meningitis, fulfilling the consensus diagnostic criteria as
described by Marais et al., were included. Patients were
categorized into definite, probable, or possible tubercu-
lous meningitis groups on the basis of clinical, imaging,
and laboratory criteria. The definite cases of tuberculous
meningitis had either the presence of acid-fast bacilli in
cerebrospinal fluid, or mycobacterium could be cultured
from cerebrospinal fluid, or cerebrospinal fluid was
positive for mycobacterial nucleic acids by polymerase
chain reaction. The probable cases fulfilled the clinical
entry criteria plus a total diagnostic score of 10 or
more points (when cerebral imaging was not available)
or 12 or more points (when cerebral imaging was
available) plus exclusion of alternative diagnoses. The
possible cases included clinical entry criteria plus a
total diagnostic score of 6–9 points (when cerebral
imaging was not available) or 6–11 points (when cere-
bral imaging was available) along with the exclusion of
alternative diagnoses [9].
Disease severity
Patients were classified as per British Medical Research
Council staging system. Patients with stage-I disease had
a Glasgow Coma Scale score of 15 with no focal neuro-
logic signs; patients with stage-II had signs of meningeal
irritation with slight or no alteration of sensorium and
minor neurological deficit (like cranial nerve palsies) or
no deficit (Glasgow coma scale score 11 to14), and pa-
tients with stage-III had severe alteration of sensorium,
convulsions, focal neurological deficit and involuntary
movements (Glasgow coma scale score <10) [10].
Evaluation of patients
All enrolled patients were subjected to detailed clinical,
radiological, and laboratory evaluation. Occurrence of
systemic tuberculosis, such as involvement of pulmonary
system, lymph node, bone, and other organs, were re-
corded. The work up included complete blood count,
peripheral blood smear examination, erythrocyte sedi-
mentation rate, blood urea nitrogen, blood sugar, serum
creatinine, serum electrolytes, liver function tests, chest
X-ray, and enzyme linked immunosorbent assay for
HIV. Cerebrospinal fluid biochemical and microscopic
examination, including India ink preparation, were per-
formed. Cerebrospinal fluid sediments were stained, cul-
tured (Lowenstein Jensen media), and tested for drug
susceptibility by standard methods. Cerebrospinal fluid
specimens were also tested for mycobacterial nucleic
acids by polymerase chain reaction. Appropriate patients
were also evaluated by performing bacterial screen with
culture, cryptococcal latex antigen detection, antinuclear
antibody, antineutrophil cytoplasmic antibody screen,
hepatitis B and C, and angiotensin converting enzyme
level. Patients were subjected to MR imaging of the
brain and/or spinal cord using Signa Excite 1.5 Tesla
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instrument (General Electric Medical Systems, Milwau-
kee, WI, USA.
Exclusion criteria
Patients with cryptococcal meningitis or any other cause
for meningitis were excluded from the study.
Definition of paradoxical reaction
A paradoxical reaction was defined as the worsening
of pre-existing tuberculous lesions or the appearance
of new tuberculous lesions in patients whose clinical
symptoms initially improved and had been on anti-
tuberculosis treatment for at least 10 days [2, 3, 11].
For the purpose of the calculation of “time of onset of
paradoxical reaction” in the study participants only
clinical deteriorations were considered from the time
of initiation of anti-tuberculosis treatment; non-
symptomatic radiological worsening was defined either
at the time of clinical deteriorations or at the pre-
defined follow-up visit.
Definition of other neuroimaging findings
Hydrocephalus was defined as ventriculomegaly with
Evan’s ratio (maximal width of frontal horns/maximal
width of inner skull) of more than 30 % and/or size of
one or both temporal horns greater than 2 mm. Com-
municating hydrocephalus was characterized with ven-
triculomegaly with a dilated fourth ventricle. Meningeal
inflammation, on gadolinium-enhanced MRI, was de-
fined as an enhancement of pia-arachnoid mater cover-
ing subarachnoid spaces of the sulci and basal cisterns.
Exudates were defined as a thick area of enhancement,
predominantly in basal cisterns and Sylvian fissure.
Optochiasmatic tuberculoma and arachnoiditis were
characterized with confluent enhancing lesions involving
interpeduncular fossa, pontine cistern, and perimesence-
phalic and suprasellar cisterns. Spinal arachnoiditis was
defined with the presence of enhancement of spinal
meninges, and nerve roots, obliteration of the spinal
subarachnoid space, cysts and loculations in subarach-
noid space, or syrinx formation. Tuberculomas were de-
fined as discrete or coalescing cerebral masses showing
nodular or ring shaped enhancement. Infarcts were areas
of abnormal signal intensity in a vascular distribution,
predominantly in periventricular region. Infarcts ap-
peared hyperintense on T2-weighted images and hypoin-
tense on T1-weighted images, with corroborating
changes on diffusion-weighted and apparent diffusion
coefficient images.
Treatment
All included patients received anti-tuberculosis treat-
ment as per World Health Organization guidelines for
the treatment of central nervous system tuberculosis.
Patients received 2 months of daily oral isoniazid
(5 mg/ kg of body weight; maximum, 300 mg), rifam-
picin (10 mg/ kg; maximum, 600 mg), pyrazinamide
(25 mg/kg; maximum, 2 g/day) and intramuscular
streptomycin (20 mg/kg; maximum 1 gm/day),
followed by at least 7 months administration of isonia-
zid and rifampicin [12]. Corticosteroid regimen con-
sisted of intravenous dexamethasone for 4 weeks
(0.4 mg/kg body weight per day and then tapered off
decreasing 0.1 mg/kg every week) and then oral treat-
ment for 4 weeks, starting at a total of 4 mg per day
and decreasing by 1 mg each week [13]. Pyridoxine
was given orally 20–40 mg/day to all the patients. In
addition, patients received symptomatic treatment as
well. Neurosurgical opinion was sought, whenever
required.
In HIV-infected patients antiretroviral therapy was
administered under supervision of the Nodal anti-
retroviral therapy unit. Antiretroviral therapy was
started as soon as anti-tuberculosis treatment was
tolerated (between 2 weeks and 2 months), as per
National AIDS Control Organization, Government of
India, guidelines [14].
Disability assessment
Disability assessment was done using Barthel index (BI),
which is a 20 point scoring system. Assessment of dis-
ability included degree of dependence for bowel and
bladder, grooming, toilet use, transfer, mobility, dressing,
feeding, use of stairs and bathing. For each activity, a
score of 0 indicated a complete dependence, and an indi-
vidual score of 2 or 3 indicated that the patient was able
to perform activities independently. A score of ≤ 12 indi-
cated poor functional status and a score of >12 indicated
good functional status.
Follow up
Patients were regularly followed up for 9 months. Be-
sides a defined follow up at 3, 6, and 9 months, clinical
assessment and cerebrospinal fluid analysis were also
done at the time of clinical deterioration. Changes in
cerebrospinal fluid parameters (like cells, protein and
sugar) were noted. Polymorphonuclear predominance
was defined when these constituted >50 % of cells.
Repeat neuroimaging were performed after 3 months
and 6 months, or at periods of clinical deteriorations.
Neuroimaging were looked for any deterioration or new
findings. Assessment of disability was done at the end
9 months of follow up. Barthel index >12 was considered
as good outcome. Intervening visits mandated by clinical
deteriorations generated off-pre-defined visit data which
was additionally recorded.
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Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences, version 16 for windows
(SPSS, Chicago IL, USA). Both univariate and multivari-
ate analysis were done to evaluate the predictors of para-
doxical reaction. Univariate analysis was performed by
Chi-square test for categorical variables and independent
sample “t” test for continuous variables. Odds ratio with
95 % confidence interval were ascertained. For multivari-
ate analysis, binary logistic regression was performed to
see the impact of individual predictors of paradoxical re-
action. Paired sample “t” test and McNemar tests were
used to compare quantitative and qualitative variables
before and during development of paradoxical reaction.
Kaplan Meier analysis was performed to estimate the
event free survival for the outcome with or without
baseline paradoxical reaction using the Log Rank test.
Statistical significance was defined at a p value of <0.05.
All statistical analyses were two-tailed.
Results
Baseline characteristics
We screened 156 consecutive patients of tuberculous
meningitis during the study period which ranged from
October 2013 to March 2015. Fifteen patients were ex-
cluded. Reasons for exclusion of 15 patients have been
provided in Fig. 1. Finally, 141 patients were included
and evaluated. Majority of our patients 66 (46.8 %), at
inclusion, were in stage-II. Thirteen patients were HIV
positive. There were 54 (38.3 %) microbiologically-
confirmed cases. One patient had multidrug resistant
tuberculous meningitis and was included in the non-
paradoxical reaction group. In the paradoxical reaction
group the mean duration of illness was 42.93 ± 21.58 (me-
dian = 38, range 18–107) days while in the non-paradoxical
reaction group the mean duration of illness was 52.49 ±
27.54 (median = 45, range 5–180) days (Table 1).
Incidence of paradoxical reaction
In our study, 44 (31.2 %) patients developed some form
of paradoxical reaction. In majority (29 patients), para-
doxical reactions were noted within 3 months of start of
anti-tuberculosis treatment. Mean duration of paradox-
ical reaction was 82.45 days (16–320 days) (Additional
file file 1: Table S1).
Manifestations of paradoxical reaction
Fever, headache, altered sensorium, decreased vision,
and seizures were common clinical paradoxical reactions
among 44 patients who presented with a paradoxical re-
action. Among neuroimaging changes, enhancing basal
exudates, a new or enlargement of pre-existing tubercu-
loma, development of infarcts, and increasing ventricu-
lomegaly were the more frequent paradoxical reactions.
Twenty-six (59 %) patients developed either a new (15
patients) or enlargement (11 patients) of pre-existing
tuberculoma. Twenty patients demonstrated newly de-
veloped hydrocephalus while in 7 cases ventricular size
had increased further. Optochiasmatic arachnoiditis was
the other common but disabling paradoxical manifest-
ation. Four patients, additionally, had spinal arachnoidi-
tis. In 41 patients, cerebrospinal fluid paradoxically
Fig. 1 Flow chart of the study
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Table 1 Baseline characteristics, radiological and cerebrospinal fluid parameters, and outcome of patients with tuberculous meningitis







Age (Mean±SD) 29.75±12.79 27.295±10.95 30.866±13.44
Duration of illness (Mean±SD) 49.51±26.13 42.932±21.58 52.495±27.53
Gender (n, %)
Male 76(53.9 %) 18(40.9 %) 58(59.8 %)
Female 65(46.1 %) 26(59.1 %) 39(40.2)
HIV (n, %) 13(9.2 %) 11(25 %) 2(2.1 %)
Clinical (n, %)
BMRC stage 1 31(22.0 %) 8(18.2 %) 23(23.7 %)
BMRC stage 2 66(46.8 %) 21(47.7 % 45(46.4 %)
BMRC stage 3 44(31.2 %) 15(34.1 %) 29(29.9 %)
Fever 138(97.8 %) 43(97.7 %) 95(97.9 %)
Headache 131(92.90 %) 39(88.6 %) 92(94.8 %)
Seizure 48(34.0 %) 12(27.3 %) 36(37.1 %)
Altered Sensorium 44(31.2 %) 15(34.1 %) 29(29.9 %)
Decreased vision 35(24.8 %) 10(22.7 %) 25(25.8 %)
Hemiparesis 23(16.3 %) 7(15.9 %) 16(16.5 %)
Paraparesis 12(8.5 %) 2(4.5 %) 10(10.3 %)
Meningeal signs 125(88.7 %) 41(93.2 %) 84(86.6 %)
Lymphadenopathy 13(9.2 %) 10(22.7 %) 3(3.1 %)
Diplopia 59(41.8 %) 17(38.6 %) 42(43.3 %)
Cranial Nerve involvement 80(56.7 %) 27(61.4 %) 53(54.6 %)
Papilloedema 50(62.5 %) 13(29.5 %) 42(43.3 %)
Imaging (n, %)
Hydrocephalus 53(37.6 %) 13(29.5 %) 40(41.2 %)
Basal Exudates 38(27.0 %) 9(20.5 %) 29(29.9 %)
Tuberculoma 51(36.2 %) 15(34.1 %) 36(37.1 %)
Infarct 25(17.7 %) 7(15.9 %) 18(18.6 %)
Optochiasmatic arachnoiditis 21(14.9 %) 7(15.9 %) 14(14.4 %)
Spinal arachnoiditis 12(8.5 %) 2(4.5 %) 10(10.3 %)
Cerebrospinal fluid
White blood cells (cells/mL±SD) 189.610±185.66 200.864±121.26 184.505±208.809
Protein mg% 253.704±455.84 188.5382±115.145 283.2649±542.511
Sugar mg% 35.311±18.46 33.620±18.231 36.086±18.61
Neutrophil differential in percentage,
mean±SD
17.21±19.250 19.705±21.368 16.072±18.210
Lymphocyte differential in percentage
(mean±SD)
83.65±18.02 80.295±21.368 85.175±16.166
AFB smear (n, %) 4(2.8 %) 1(2.27 %) 3(3.09 %)
AFB culture positive (n, %) 21(14.9 %) 11(25 %) 10(10.30 %)
TB PCR-positive (n, %) 50(35.5 %) 22(50 %) 28(28.86 %)
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worsened (increase in cells with or without rise in pro-
tein level). Out of the remaining 3, two patients demon-
strated a decrease in the cell count but with polymorph
predominance (not present at the baseline) while in one
the cerebrospinal fluid was normal. In cerebrospinal
fluid, major changes observed were increase in protein
level and increase in polymorphs. In 3 patients with
paradoxical reaction, only cerebrospinal fluid changes
(without imaging changes) were noted. Fourteen patients
had paradoxical lymphadenopathy while three patients
had developed miliary tuberculosis (Fig. 2) (Additional
file 1: Table S1). Statistically significant changes from the
baseline to the time of development of paradoxical reac-
tion was observed in fever, headache, hydrocephalus,
tuberculoma, c-reactive protein, erythrocyte sedimenta-
tion rate, and cerebrospinal fluid polymorphs, lympho-
cytes, and protein (Table 2).
Predictors of paradoxical reaction
On univariate analysis, female gender (p = 0.037), HIV posi-
tivity (p = <0.001), lymphadenopathy (p = 0.001) and a
shorter duration of illness (p = 0.028) were significantly as-
sociated with development of paradoxical reaction (Table 3).
On multivariate analysis, female gender (p = 0.013, OR
=2.87, CI 1.24-6.62), HIV positivity (p = 0.010, OR =
31.49; CI = 2.31-426.21), and a shorter duration of
illness (p = 0.049, OR = 0.98 CI = .963-1.00) were
found to be statistically significant predictors of
paradoxical reaction (Table 4).
Impact on prognosis
Overall, duration of illness, alteration in consciousness,
stage-III of tuberculous meningitis, and hydrocephalus
predicted poor prognosis among patients with tubercu-
lous meningitis. In the paradoxical group 24 % patients
had poor outcome compared to 35.2 % with good out-
come, which was statistically not significant (Table 5).
We did not observe any significant difference in the
proportion of patients having poor disability status after
end of follow up. Kaplan-Meier survival statistics did not
demonstrate any significant difference in survival be-
tween both groups (Fig. 3).
Discussion
In this prospective study approximately one-third of pa-
tients with tuberculous meningitis developed paradoxical
Table 1 Baseline characteristics, radiological and cerebrospinal fluid parameters, and outcome of patients with tuberculous meningitis
(Continued)
Diagnostic category (n, %)
Definite 54(38.3 %) 20(45.5 %) 34(35.1 %)
Probable 62(44.0 %) 19(43.2 %) 43(44.3 %)
Possible 25(17.7 %) 5(11.4 %) 20(20.6 %
Disability (n, %)
Baseline BI(<12) 93(66.0 %) 34(77.3 %) 59(60.8 %)
Baseline BI(>12) 48(34.0 %) 10(22.7 %) 38(39.2 %)
Outcome (n, %)
Poor (BI<12) 50(35.5 %) 12(27.3 %) 38(39.2 %)
Good (BI>12) 91(64.5 %) 32(72.7 %) 59(60.8 %)
AFB acid fast bacilli, BMRC British Medical Research Council, HIV human immunodeficiency virus, BI Barthel index, TB PCR tuberculosis polymerase chain reaction
Fig. 2 T1-weighted Gadolinium-enhanced MRI (axial sections) of the
brain of a patient with TBM depict the development of additional
(paradoxical) tuberculoma (Baseline-a, at 5th month-b) at the
pontocerebellar level. Similar sequence in another patient shows
development of paradoxical optochiasmatic arachnoiditis along
with multiple tuberculomas (Baseline-c, at 3rd month-d)
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changes. In almost all patients, clinical/imaging paradox-
ical manifestations accompanied paradoxical cerebro-
spinal fluid changes. We encountered a variety of
manifestations of paradoxical reactions. These paradox-
ical clinical and neuroimaging manifestations were either
aggravated or appeared for the first time during illness,
despite of an adequate anti-tuberculosis treatment. Ex-
pansion of existing cerebral tuberculomas and appear-
ance of new tuberculomas, hydrocephalus, and
optochiasmatic and spinal arachnoiditis, were common
paradoxical manifestations.
Paradoxical reactions in these patients result because
of an excessive inflammatory response against mycobac-
terial antigens. Mycobacterial cell wall antigens are
present in the affected brain tissues and trigger an exag-
gerated inflammatory reaction following treatment with
anti-tuberculosis drugs. Cheng and colleagues had noted
a surge in blood lymphocyte counts accompanied by an
increased tuberculin skin reaction during paradoxical re-
sponse indicating that this immune response is similar
to immune restoration syndrome seen in HIV-infected
patients. Possibly, due to a paradoxical shift in the cellu-
lar components of the cerebrospinal fluid (from lympho-
cytic predominance to polymorph predominance),
neutrophils also play a role in the pathogenesis of para-
doxical reaction in patients with tuberculous meningitis.
[15] Sütlaş and co-workers followed 61 patients with
confirmed or presumed tuberculous meningitis. Patients
were categorized into two groups according to the pres-
ence of paradoxical response (progressive increase of
lymphocytes or increase of polymorphonuclear cells in-
stead of lymphocytes) in cerebrospinal fluid samples.
Paradoxical response in the cerebrospinal fluid was seen
in 20 patients. New tuberculomas developed more fre-
quently in the group having paradoxical cerebrospinal
fluid response. We had similar observations in our study
where 41 patients with clinical/imaging paradoxical
changes had paradoxical cerebrospinal fluid changes.
Interestingly, in two patients where the cells actually
decreased, there was a shift towards polymorph pre-
dominance. It has been observed that paradoxical
cerebrospinal fluid changes occur after several weeks
of starting anti-tuberculosis treatment and may not be
associated with any clinical or neuroimaging deterior-
ation [16].
We observed that female gender, concomitant HIV in-
fection, and a shorter duration of illness, were significant
predictors of paradoxical reactions in patients with tu-
berculous meningitis. Females exhibit more-robust im-
mune responses to antigenic challenges, like infection
and vaccination, in comparison to that in males. Given
the fact that immune cells express specific receptors for
Table 2 Comparative analysis of variables of patients with paradoxical reaction
Variable At baseline During pxaradoxical reaction P value
Fever 43 29 .001
Headache 39 27 .008
Seizure 12 11 1.0
Altered Sensorium 15 12 .664
Decreased vision 10 16 .180
Hemiparesis 7 9 .791
Paraparesis 2 4 .688
Hydrocephalus 13 27 .009
Tuberculoma 15 26 .019
Basal Exudate 9 12 .648
Optochiasmatic arachnoiditis 7 12 .332
Infarct 7 9 .791
Spinal arachnoiditis 2 4 .688
CRP 19 28 .004
ESR 27.818±4.876 33.20±5.889 .027
CSF cells 200.864±121.260 210.295±125.761 .058
CSF Polymorph 19.705±21.368 37.84±23.716 .008
CSF Lymphocytes 80.295±21.368 62.39±23.398 .012
CSF Protein 188.538±115.145 261.355±152.0650 <.001
CSF sugar 33.620±43.2566 43.256±17.998 .261
CRP C-reactive protein, CSF cerebrospinal fluid, ESR Erythrocyte sedimentation rate
Note: Statistically significant P-values are depicted in italics
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sex hormones and are responsive to changes in hormone
levels, this gender variation might be explained by the
modulatory effect of female sex hormones on the im-
mune response towards Mycobacterium tuberculosis as-
sociated antigens [17, 18].
Patients with disseminated or extrapulmonary disease
are considered to have higher bacillary/antigen loads,
with a relative immunodeficient response, resulting in an
increased risk of both paradoxical reactions and IRIS.
Use of bactericidal drugs, such as isoniazid, may cause a
massive release of bacterial components and provoke
Table 3 Predictors of paradoxical reaction on univariate analysis
Characteristic Paradoxical reaction P value Odds
ratio
95 % Confidence interval
Present (n=44) Absent (n=97) Lower bound Upper bound
Age in years Mean ± SD 27.295 ± 10.958 30.866 ± 13.446 0.125 −1.004 8.145
Duration of illness (days) Mean ± SD 42.932± 21.583 52.495± 27.538 0.028 0.276 18.850
Gender (female) 26 (59.1 %) 39 (40.2 %) 0.037 2.148 1.04 4.436
HIV positive 11(25 %) 2(2.1 %) <0.001 15.833 3.334 75.184
Fever 43(97.7 %) 95(97.9 %) 0.936 0.905 0.080 10.255
Headache 39(88.6 %) 92(94.8 %) 0.183 0.424 0.116 1.548
Seizure 12(27.3 %) 36(37.1 %) 0.253 0.635 0.291 1.387
Altered Sensorium 15(34.1 %) 29(29.9 %) 0.618 1.213 0.567 2.593
Decreased vision 10(22.7 %) 25(25.8 %) 0.698 0.847 0.366 1.960
Hemiparesis 7(15.9 %) 16(16.5 %) 0.930 0.958 0.363 2.526
Paraparesis 2(4.5 %) 10(10.3 %) 0.341 0.414 0.087 1.976
Meningeal signs 41(93.2 %) 84(86.6 %) 0.253 2.115 0.571 7.837
Lymphadenopathy 10(22.7 %) 3(3.1 %) 0.001 9.216 2.393 35.496
Diplopia 17(38.6 %) 42(43.3 %) 0.603 0.825 0.398 1.707
Cranial Nerve involvement 27(61.4 %) 53(54.6 %) 0.455 1.319 0.638 2.727
Papilloedema 13(29.5 %) 42(43.3 %) 0.121 0.549 0.256 1.177
Hydrocephalus 13(29.5 %) 40(41.2 %) 0.184 0.598 0.279 1.282
Basal Exudates 9(20.5 %) 29(29.9 %) 0.242 0.603 0.257 1.413
Tuberculoma 15(34.1 %) 36(37.1 %) 0.729 0.876 0.415 1.850
Infarct 7(15.9 %) 18(18.6 %) 0.703 0.830 0.319 2.161
Optochiasmatic Arachnoiditis 7(15.9 %) 14(14.4 %) 0.820 1.122 0.418 3.008
Spinal cord 2(4.5 %) 10(10.3 %) 0.256 0.414 0.087 1.976
CRP 19(43.2 %) 38(39.2 %) 0.653 1.180 0.573 2.430
Stage 3 TBM 15(34.1 %) 29(29.9 %) 0.618 1.213 0.567 2.593
Baseline BI (<12) 34(77.3 %) 59(60.8 %) 0.056 2.190 0.970 4.944
Definite TBM 20(45.5 %) 34(35.1 %) 0.312 1.544 .748 3.189
Good outcome (BI>12) 32(72.7 %) 59(64.8 %) 0.171 0.582 0.267 1.268
ESR mm in 1 h Mean ± SD 27.818 ± 4.876 27.093 ± 7.593 0.497 −3.194 1.743
CSF Cells/μL Mean ± SD 200.864 ± 121.261 184.505 ± 208.810 0.630 83.265 56.548
CSF protein (mg/dl) Mean ± SD 188.5382 ± 115.145 283.2649 ± 542.511 0.254 −68.924 258.377
CSF sugar (mg/dl) Mean ± SD 33.620 ± 18.231 36.086 ± 18.617 0.465 4.193 9.125
BI Barthel Index, CRP C-reactive protein, CSF cerebrospinal fluid, ESR Erythrocyte sedimentation rate, HIV Human Immunodeficiency Virus, TBM
Tuberculous meningitis
Note: Statistically significant P-values are depicted in italics
Table 4 Predictors of paradoxical reaction on multivariate
analysis
Characteristic P value Odds
ratio
95 % Confidence interval
Lower bound Upper bound
Duration .049 .981 0.963 1.000
Gender (female) .013 2.873 1.246 6.626
HIV .010 31.407 2.314 426.215
Lymphadenopathy .813 0.746 0.066 8.465
HIV human immunodeficiency virus
Note: Statistically significant P-values are depicted in italics
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inflammatory changes that could produce clinical deteri-
oration and imaging changes [19]. Another significant
predictor of paradoxical reaction was a shorter duration
of illness. Possibly, a large mycobacterial load and subse-
quent release of mycobacterial antigen following anti-
tuberculosis treatment resulted in a higher frequency of
paradoxical reactions among patients who developed tu-
berculous meningitis comparatively rapidly.
A substantial proportion of our HIV-infected patients (11
out of 13 patients) developed paradoxical reactions. Many
studies in the past have noted that many patients develop
tuberculous meningitis associated IRIS. Manifestations of
central nervous system tuberculosis IRIS include meningi-
tis, cerebral parenchymal tuberculoma, brain abscesses,
spinal cord complications like myeloradiculopathy, and
spinal epidural abscesses [20–22]. In a prospective study,
47 % (16/34) of tuberculous meningitis patients developed
tuberculous meningitis-IRIS. At inclusion, tuberculous
meningitis-IRIS patients had a higher cerebrospinal fluid
neutrophil counts compared with non-tuberculous
meningitis-IRIS patients [20]. There is a consensus that
antiretroviral therapy should be started early (around
2 weeks) in HIV/tuberculosis co-infected patients. In HIV
and tuberculous meningitis co-infected patients, because of
a potential risk of tuberculous meningitis associated IRIS,
antiretroviral therapy may be delayed; however, there is no
consensus on this point [23].
We observed that the development of paradoxical
reactions did not adversely affect the outcome of tu-
berculous meningitis. Several studies in the past had
Table 5 Predictors of disability and outcome on univariate analysis in patients with tuberculous meningitis
Characteristics BI≤12 (n=50) BI>12 (n=91) P value Odds
Ratio
95 % Confidence interval
Lower bound Upper bound
Age 29.320±11.881 29.989±13.322 .768 −3.797 5.135
Duration of illness 42.140±21.204 53.560±27.761 .013 2.495 20.345
Gender 22(44 %) 54(59.3 %) .080 .538 .268 1.082
HIV
Fever 49(98 %) 89(97.8 %) .938 1.101 .097 12.453
Headache 44(88 %) 87(95.6 %) .092 .337 .090 1.257
Seizure 15(30.0 %) 33(36.3 %) .453 .753 .359 1.580
Altered Sensorium 31(62.0 %) 13(14.3 %) <.001 9.789 4.316 22.206
Decreased vision 16(32.0 %) 19(20.9 %) .144 1.783 .817 3.891
Hemiparesis 9(18.0 %) 14(15.4 %) .688 1.207 .482 3.027
Paraparesis 6(12.0 %) 6(6.6 %) .271 1.932 .588 6.342
Meningeal signs 44(88.0 %) 81(89 %) .856 .905 .308 2.657
Lymphadenopathy 4(8.0 %) 9(9.9 %) .711 .792 .231 2.716
Diplopia 19(38.0 %) 40(44.0 %) .493 .821 .402 1.675
Cranial Nerve involvement 28(56.0 %) 52(57.1 %) .896 .955 .476 1.914
Papilloedema 18(36.0 %) 37(40.7 %) .587 .821 .402 1.675
Hydrocephalus 40(80.0 %) 13(14.3 %) <.001 24.0 9.677 59.520
Basal Exudates 12(24.0 %) 26(28.6 %) .558 .789 .357 1.744
Tuberculoma 22(44.0 %) 29(31.9 %) .151 1.680 .825 3.422
Infarct 9(18.0 %) 16(17.6 %) .950 1.029 .418 2.533
Optochiasmatic arachnoiditis 7(14.0 %) 14(15.4 %) .825 .895 .336 2.388
Spinal arachnoiditis 6(12.0 %) 6(6.6 %) .271 1.932 .588 6.342
Stage-III TBM 31(62.0 %) 13(14.3 % <.001 9.789 4.316 22.206
Definite TBM 23(46.0 %) 31(34.1 %) .163
Paradoxical reaction 12(24.0 %) 32(35.2 %) .171 .582 .267 1.268
CSF Cells 159.340 206.242 .152 −17.474 111.277
CSF protein 256.772 252.019 .953 −163.99 154.488
CSF sugar 35.112 35.422 .925 −6.153 6.773
CSF cerebrospinal fluid, HIV human immunodeficiency virus, BI Barthel index, TBM tuberculous meningitis
Note: Statistically significant P-values are depicted in italics
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similar observations. Clinical, laboratory, radiological,
and outcome data of 14 cases of paradoxical tuber-
culoma in tuberculous meningitis patients (out of 22
patients who had intracranial tuberculoma) were
compared with 41 tuberculous meningitis patients
without tuberculomas. The analysis suggested that
there was no statistical difference between two
groups regarding age, stage of tuberculous meningi-
tis, duration between disease onset and treatment
initiation, cerebrospinal fluid protein levels, and in
long-term disabilities [24]. Many manifestations of
paradoxical reactions like optochiasmatic and spinal
arachnoiditis, and a large cerebral tuberculoma are
serious conditions associated with severe disabilities,
and a potential for death [25]. These conditions war-
rant urgent treatment with immunomodulatory
drugs. High doses of corticosteroids are currently
the most preferred treatment. Many other immuno-
modulatory drugs like, tissue necrosis factor-α antag-
onists, thalidomide, and interferon– γ have also been
used, though sparingly [3].
There were certain limitations of our study. It is diffi-
cult to pin-point exactly the timing of onset of a para-
doxical reaction clinically. Besides this, the differential
diagnosis of a paradoxical reaction may also pose a chal-
lenge. A wrong diagnosis, possibility of treatment failure,
multidrug-resistance, atypical mycobacterial infection,
drug toxicity, or clinical deterioration due to some unre-
lated cause should always be co-considered. One of our
patients with apparent paradoxical reaction later turned
out to have multidrug-resistant tuberculosis.
Conclusion
Paradoxical reaction occurs in approximately one-
third of patients with tuberculous meningitis. Female
gender, concomitant HIV infection, and a shorter dur-
ation of illness are significant predictors of such reac-
tions. Duration of illness, alteration in consciousness,
stage-III of tuberculous meningitis, and hydroceph-
alus, predict a poor prognosis in patients with tuber-
culous meningitis; paradoxical reactions, however, do
not seem to affect the outcome adversely.
Additional file
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meningitis. (DOCX 30 kb)
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